Obesity, particularly that caused by visceral fat accumulation, is a serious risk factor for so-called lifestyle-related diseases such as diabetes, coronary heart diseases, hyperlipidemia, hypertension, and cancer. 1) Insulin resistance is considered the most common underlying abnormality in human obesity and is influenced by genetic and environmental factors, and particularly by changes in diet and physical activity. 2) High-fat-fed rodents appear to be the best model for the visceral obesity syndrome 3) because of the similar pathogenesis of obesity to that found in humans. 4) The recent and rapid increase in obesity in developed countries points to the important interaction between the series of genes that predispose to obesity and an environment that facilitates the expression of the obese phenotype, another trait shared with high-fat-diet (HFD)-induced rodent obesity models. 5) Preventive or therapeutic strategies to control most of human obesity should target these abnormalities. 6) Due to the adverse side effects associated with many of the anti-obesity drugs, more recent drug trials have focused on screening the herbal medicines that have been reported to treat obesity and that generally have minimal side effects. 7) Anti-obesity foods and food ingredients may avert the condition, possibly leading to the prevention of lifestyle-related diseases, if they are effective in reducing the visceral fat mass. 8) Traditional herbal medicines such as a Panax ginseng berry extract, 9) Zingiber officinale Roscoe, 10) and Platycodi radix 11) have been reported to be effective in managing obesity in HFD-fed mice and rats, while such natural products as Ephedra sinica, Taraxacum officinale (dandelion), and Rhamnus purshiana (cascara) have been specifically studied for weight loss in humans. 12) Garcinia cambogia, an edible fruit native to Southeastern Asia, exhibits a distinctive sweet and sour taste, and has been used for centuries in Asian countries for preparing culinary dishes. 13, 14) A Garcinia cambogia extract has been available as an anti-obesity herbal supplement around the world for decades, although some mild adverse events such as headache, and upper respiratory tract and gastrointestinal symptoms have been reported in overweight subjects. 15) Hydroxy citric acid (HCA), the principal acid in the fruits of Garcinia cambogia, is a competitive inhibitor of ATP-citrate lyase (EC 4.1.3.8), the enzyme responsible for fatty acid, cholesterol, and triglyceride biosynthesis. 16, 17) The inhibitory action of HCA reduces the acetyl-CoA pool, thus limiting the availability of the two carbon units required for the initial steps of fatty acid and cholesterol biosynthesis. 13, 16) Although the weight loss effects of Garcinia cambogia have been documented, 14, 15, 18) a comprehensive study examining its ability to combat y To whom correspondence should be addressed. Tel: +82-2-2123-3123; Fax: +82-2-365-3118; E-mail: tspark@yonsei.ac.kr Abbreviations: aP2, adipocyte P2; C/EBP, CCAAT/enhancer-binding protein ; GLUT4, glucose transporter 4; HCA, hydroxyl citric acid; HFD, high-fat diet; HFD+G, Garcinia cambogia extract-supplemented diet; ND, normal diet; PPAR2, peroxisome proliferators-activated receptor 2; SREBP1c, sterol regulatory element-binding protein 1c; TNF, tumor necrosis factor visceral adiposity in an HFD-induced obesity model is lacking. Especially, the interaction between obesityrelated genes and consumption of the Garcinia cambogia extract needs to be confirmed in animal models of diet-induced obesity.
The present work was therefore undertaken to study the effects of Garcinia cambogia on the expression of multiple genes associated with adipogenesis as well as other visceral obesity-related biomarkers in an HFDinduced obesity mouse model. The focus of this study is on the molecular effects of Garcinia cambogia on the mRNA expression of adipocyte protein aP2 (aP2), sterol regulatory element-binding factor 1c (SREBP1c), peroxisome proliferator-activated receptor 2 (PPAR2), and CCAT/enhancer-binding protein (C/EBP) in the epididymal adipose tissue of a diet-induced obesity mouse model.
Materials and Methods
Animals and diets. Thirty-six 7-wk-old male C57BL/ 6J mice (Jung-Ang Lab Animal, Seoul, Korea) were individually housed in standard cages and placed in a room where the temperature was kept at 21 AE 2:0 C, the relative humidity at 50 AE 5%, and the light on a 12-h light/dark cycle. All the mice consumed a commercial diet and tap water ad libitum for 1 wk prior to their division into three weight-matched groups: the normal diet (ND) group, HFD group, and Garcinia cambogia extract-supplemented diet (HFD+G) group. ND was a purified diet based on the AIN-76 rodent diet composition. HFD was identical to ND except that 200 g of fat/ kg (170 g of lard plus 30 g of corn oil) and 1% (w/w) cholesterol were added. HFD was formulated to provide 39% of the total energy generated by the diet from fat by replacing carbohydrate energy with lard and corn oil, and had the same amount of vitamins and minerals per kilojoule as ND did. HFD+G was identical to HFD and contained 1a % Garcinia cambogia extract composed of the natural and highly water-soluble potassium and calcium salt of 60% hydroxycitric acid (Super Citrimax Ò , HCA-600-SXS, Lot no. 0503006 supplied by InterHealth Nutraceuticals, Benicia, CA, USA.) ( Table 1 ). The diets were given in the form of pellets for 12 wk. The mice's food intake was recorded daily, and their body weights were monitored every three days, from 10:00 a.m. to 11:00 a.m., during the feeding period. At the end of the experimental period, the animals were anesthetized with ether, following a 12-h period of fasting. Blood was drawn from the inferior vena cava into a heparin-coated tube, and the plasma was obtained by centrifuging the blood at 1;000 Â g for 15 min at 4 C. The livers and visceral fat pads were removed, rinsed with phosphate-buffered saline, and then weighed. The plasma, liver and visceral fat pad samples were stored at À70 C until they were analyzed. This study adhered to the Guide for the Care and Use of Laboratory Biochemical analysis. The plasma concentrations of total cholesterol and triglyceride were determined enzymatically by using commercial kits (BioClinical System, Gyeonggi-do, Korea). Hepatic lipids were extracted as described, 19) and the dried lipid residues were dissolved in 1 ml of ethanol. The concentrations of cholesterol and triglyceride in the hepatic lipid extracts were determined by using an automatic analyzer (Express Plus, Chiron Diagnostics, East Walpole, MA, USA) with reagents (Bayer, Tarrytown, NY, USA). The plasma insulin, leptin, and adiponectin levels were measured by a radioimmunoassay (Linco Research, Charles, MO, USA). The plasma glucose concentration was measured enzymatically by using a commercial kit (BioClinical System).
Real-time RT-PCR analysis. Total RNA was isolated from the epididymal fat tissues of each mouse by using Trizol (Invitrogen, Carlsbad, CA, USA) and was reverse-transcribed using the Superscript II kit (Invitrogen) according to the manufacturer's recommendations. The GenBank accession numbers of the relevant templates and the forward (F) and reverse (R) primer sequences are shown in Table 2 . Primers were also designed to amplify the 530-bp cDNA fragment encoding -actin (sense: 5 0 -ACCTTCAACACCCCAGCCA-TGTACG-3 0 ; anti-sense: 5 0 -CTGATCCACATCTGC-TGGAAGGTGG-3 0 ) as an internal control. Real-time PCR reactions were then carried out in a 20-ml reaction mixture (2 ml of cDNA, 16 ml of SYBR green PCR master mix, which included 2 ml of 1ÂLightCycler, 2.4 ml of 1.5 mmol/l MgCl 2 and 11.6 ml of H 2 O, and 1 ml of 0.5 mmol/l of a specific gene primer pair) in a LightCycler instrument (Roche Diagnostics, Indianapolis, IN, USA).
The PCR program was initiated by 10 min at 95 C, before 40 thermal cycles, each of 10 s at 95 C, 5 s at 55 C, and 30 s at 70 C. The data obtained were analyzed by using the comparative cycle threshold method, and were normalized by the -actin expression value. Melting curves for each PCR reaction were generated to ensure the purity of the amplification product.
Statistical analysis. All the results obtained are expressed as the mean AE SEM of 12 mice in each group. Statistical evaluation was done by using one-way ANOVA and followed by Duncan's multiple-range test.
The level of significance was set at p < 0:05 for all statistical tests.
Results

Body weight and visceral fat-pad weights
The body weights in the ND, HFD, and HFD+G groups began to diverge from d 24 and stayed different for the remainder of the experimental period (p < 0:05) (Fig. 1) . The final body weight and 12-wk body weight gain of mice in the HFD group were 43% and 202% greater, respectively, than the equivalent values for the ND mice. Dietary supplementation with the Garcinia cambogia extract significantly reduced the final body weight (22% lower) and body weight gain (46% lower) of the mice consuming HFD. The food intake and food efficiency ratio (FER) of mice in the HFD+G group were significantly lower than the values for the HFD group (p < 0:05) ( Table 3) .
The relative weights of the total visceral fat depots were significantly higher by feeding HFD than the value for the ND mice (137% greater, p < 0:05) and were significantly lower by supplementing HFD with the Garcinia cambogia extract (39% lower, p < 0:05). The epididymal, perirenal, retroperitoneal, and mesenteric fat-pad weights were reduced by 37%, 48%, 36%, and 42%, respectively, in the mice fed HFD+G than in the HFD mice (p < 0:05) (Fig. 2) . The adipocytes from the epididymal fat-pad of the mice fed HFD+G were 34% smaller than those of the animals fed HFD (Fig. 3) .
Plasma and hepatic biochemistry
The HFD-induced hypercholesterolemia was significantly improved by dietary supplementation with the Garcinia cambogia extract. The plasma total cholesterol and triglyceride concentrations were 24% and 25% lower, respectively, in the mice fed with HFD+G than those for the HFD-fed mice (p < 0:05). The enlargement of the liver and the accumulations of triglyceride and cholesterol in the liver of the mice fed HFD were ameliorated by dietary supplementation with the Garcinia cambogia extract (a 18% reduction in the liver weight, p < 0:05; 14-15% reductions in the hepatic triglyceride and cholesterol levels, p < 0:05). The elevated levels of plasma insulin and leptin which had been caused by feeding HFD were reduced by 43% and 52%, respectively, by dietary supplementation with the Garcinia cambogia extract (p < 0:05). The plasma glucose and adiponectin levels were not affected by the experimental diets (Table 3) .
Expression levels of adipogenesis-related genes
Results from the real-time RT-PCR analyses of total RNA prepared from the epididymal adipose tissue of mice indicate that HFD significantly down-regulated the expression of the SREBP1c, C/EBP, and PPAR2 genes, whereas it significantly up-regulated the TNF gene. The aP2 gene expression tended to be decreased in the mice fed with HFD than in the ND animals, but without showing statistical significance. These HFDinduced changes in the expression pattern of the edipidymal adipose tissue genes implicated in adipogenesis were reversed by feeding the Garcinia cambogia extract. Significant up-regulation of the aP2 (120% increase, p < 0:05), SREBP1c (12% increase, p < 0:05), C/EBP (174% increase, p < 0:05), and PPAR2 (70% increase, p < 0:05) genes, in conjunction with significant down-regulation of the TNF gene (20% reduction, p < 0:05) were observed in the epididymal adipose tissue of mice fed with HFD+G compared to those observed in the HFD mice (p < 0:05) (Fig. 4) .
Discussion
HCA, an active ingredient of the Garcinia cambogia extract, reduces food consumption in humans and in rodent models of obesity by possibly diverting carbohydrates and fatty acids that would have become fat in the liver into hepatic glycogen. 13, 14, 17, 18) This metabolic change may send a signal to the brain that results in a reduced appetite. 16) In the present study, a suppressed food intake does not appear to be the only cause of weight loss in the mice fed with the Garcinia cambogia extract, since, in addition to the food intake, FER was also significantly lower in this group than in the HFD mice, which implies that the mice administered the Garcinia cambogia extract were less efficient in transforming the nutrients fed into their own biomass. HCA resulted in a significant increase in the serum serotonin level, concomitant with a reduced appetite, weight loss, a favorable lipid profile, and a reduction in the plasma leptin level in human clinical trials. 20) The brain serotonin level has also been increased by HCA in obese Zucker rats.
21) It therefore appears that the ability of the Garcinia cambogia extract to reduce body weight gain could have been due to its combined effects on the metabolic and serotonin pathways. 21) The plasma and hepatic concentrations of cholesterol and triglyceride were significantly lower in animals that were given the Garcinia cambogia extract than in the HFD control mice. These results were expected because HCA is known to inhibit the lipogenesis catalyzed by ATP citrate-lyase in the liver and peripheral tissues, as reported previously. 22) It is well known that HCA prevents the production of acetyl-CoA and, subsequently, malonyl-CoA. 23) The results of the present study clearly show that the Garcinia cambogia extract ameliorated HFD-induced hyperinsulinemia. In addition, Garcinia cambogia, in a previous report by other investigators, restored the impaired glucose tolerance in obese Zucker rats. 24) Taken together, these results suggest that the Garcinia cambogia extract might have a beneficial role in improving the insulin resistance induced by HFD, although the mechanism for this needs to be clarified.
Leptin is a fat-derived key regulator of appetite and energy expenditure, and is exclusively secreted by adipocytes in proportion to their triglyceride stores. 25) Thereby, the circulating leptin level is correlated with the extent of obesity. 26) In the present study, the Garcinia cambogia extract decreased not only the leptin concentration but also the sizes of adipocytes, indicating that it decreased lipid accumulation in the visceral adipocytes of rats rendered obese by HFD. Adiponectin is also secreted by fat cells and has anti-atherosclerotic and insulin-sensitizing properties that suppress the hepatic glucose production and enhance the glucose uptake into the skeletal muscles.
27) In the current study, feeding HFD to mice did not lead to any significant decrease in the plasma adiponectin level. The inverse association of body weight and the serum adiponectin level has not been observed consistently in rodent models, 27) although Barnea, M., et al. 28) have recently reported that the circulating adiponectin level of mice fed HFD remained relatively constant and was highly regulated by a mechanisms that has yet to be investigated.
To maintain lipid homeostasis, adipocytes carry out two reciprocal biochemical processes: lipogenesis and lipolysis. These two processes are tightly controlled by several hormones, lipid metabolites, and nutritional conditions such as feeding and fasting. With these signals, lipogenic transcription factors, including SREBP1c, liver X receptors, PPAR, and C/EBP, actively participate in the lipid metabolism of adipocytes. 29) These transcription factors are highly expressed in the adipose tissue and play a key role in adipocyte differentiation by coordinating lipogenic and adipocytespecific gene expression. 30) PPAR, one of the first identified nuclear receptors which bind many fatty acids as ligands, interacts with several other transcription factors.
31) C/EBP and PPAR are initially expressed at low levels, and are then able to induce each other's expression via a positive feedback loop in the differentiated adipocytes. 32) Another transcription factor that PPAR interacts with is SREBP1. Co-expression of this transcription factor with PPAR increases the transcriptional activity of PPAR. Since SREBP1 is able to increase the expression of several genes involved in fatty acid metabolism, it has been suggested that SREBP1 induces the production of an endogenous ligand that enhances the transcriptional activity of PPAR. 33) Several genes specializing in lipid metabolism and storage are induced in the adipogenic differentiation process, many of which contain functional PPAR-response elements. aP2, which is a marker of terminal adipocyte differentiation and involved in free fatty acid transportation and shunting within the cell, is one such gene, 34) together with a cluster of other adipocyte-specific genes such as adiponectin, insulin receptor, leptin, glucose transporter 4 (GLUT4) and glycerol phosphate dehydrogenase. 30) In the present study, the aP2, SREBP1c, C/EBP, and PPAR2 mRNA levels were not increased, but rather decreased in the visceral adipose tissue of HFD-induced obese mice. This is in agreement with the previous reports, showing that the fatty acid synthase, acetyl-CoA carboxylase 1, and SREBP1c mRNA concentrations were decreased in the adipose tissue of obese human subjects 35) and of the obese animal models. 36) The HFD-induced down-regulation of the PPAR2 and C/EBP genes supports the response seen after the treatment of 3T3-L1 adipose cells with TNF.
37) These could be explained as an adaptive response of the visceral adipose tissue aimed at limiting a further expansion of fat storage in the adipose tissue. From a proteomic approach, Schmid, G. M., et al. 38) have observed that the proteins involved in oxidative phosphorylation were over-expressed in the brown adipose tissue of rats by feeding HFD. Therefore, the adaptive response of animals to HFD does not appear to be limited to the visceral fats, but expanded into the brown adipose tissue for the purpose of increasing energy expenditure to compensate for the weight gain.
TNF is involved in pro-inflammation, apoptosis, lipid metabolism, and insulin resistance. 39) Both the mRNA and protein expression of TNF are increased in the adipose tissue from obese rodents and humans, 40) and a high level of TNF suppresses such transcription factors as PPAR and C/EBP which, in turn, activates the GLUT4 gene. 41, 42) The addition of TNF to such adipocytes as 3T3-L1 and TA1 causes down-regulation of enzymes involved in lipid metabolism and of such adipocyte specific genes as aP2 and fat-specific protein 27. 43, 44) Xing H., et al. 42) have observed that TNF prevented the mRNA expression of PPAR and corresponding proteins from increasing in the adipogenic cells (3T3-L1 cells). The expression levels of PPAR2 and C/EBP in the epididymal adipose tissue showed significantly more up-regulation (70-174% increases) in the animals fed with HFD supplemented with the Garcinia cambogia extract than in the mice fed with HFD alone in the present study. These remarkable changes in the mRNA expression of PPAR2 and C/EBP induced by the Garcinia cambogia extract supplemented to HFD were also associated with noticeable regulation of the aP2 gene (a 120% increase), one of the target genes of PPAR. These results are in agreement with the previous observation by other investigators that the inhibitory effect of the Garcinia cambogia extract against the insulin-induced differentiation of 3T3-L1 cells targeted the adipogenic transcription factor, C/ EBP. 45) Furthermore, the result that the expression of the TNF gene, which was up-regulated by HFD, was down-regulated again by the Garcinia cambogia extract supplemented to HFD corresponds well with the dietinduced changes in the expression of such other genes as PPAR2, C/EBP, and SREBP1c. Therefore, the Garcinia cambogia extract appears to have modulated the expression of a critical nuclear transcription factor that can trigger the entire process of adipocyte differentiation. It could be speculated from the gene expression data, together with the relevant biochemical results for mice, that the blood levels of insulin and leptin, and the visceral fat-pad weights might have inverse relationships with the expression levels of PPAR2, C/EBP, SREBP1c, and aP2, and that they might be positively related with the TNF expression level in their visceral adipose tissues.
In conclusion, the Garcinia cambogia extract was effective in reducing the body weight gain, and in improving fatty liver, dyslipidemia, hyperinsulinemia, and hyperleptinemia in mice rendered obese by HFD. We report here for the first time that these anti-obesity effects of the Garcinia cambogia extract were associated with modulation of the multiple genes associated with visceral adipogenesis such as PPAR2, SREBP1c, C/EBP, and aP2 in the visceral fat tissue of mice.
